The store will not work correctly when cookies are disabled.
6-bromo-1-(1H-pyrrol-1-yl)-2,3,4,9-tetrahydro-1H-carbazole
ID: ALA5279134
Max Phase: Preclinical
Molecular Formula: C16H15BrN2
Molecular Weight: 315.21
Associated Items:
Names and Identifiers
Canonical SMILES: Brc1ccc2[nH]c3c(c2c1)CCCC3n1cccc1
Standard InChI: InChI=1S/C16H15BrN2/c17-11-6-7-14-13(10-11)12-4-3-5-15(16(12)18-14)19-8-1-2-9-19/h1-2,6-10,15,18H,3-5H2
Standard InChI Key: DSXSCWMFRNQSCG-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 22 0 0 0 0 0 0 0 0999 V2000
-2.1033 0.6253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3887 1.0376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6768 0.6257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6768 -0.1994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3869 -0.6111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1033 -0.2031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1079 -0.4543 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.1079 0.8807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5929 0.2130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4436 1.6345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2643 1.7207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7492 1.0530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4136 0.2992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8261 -0.4153 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.6464 -0.5014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8179 -1.3083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1036 -1.7207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4907 -1.1688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8179 1.0379 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
4 7 1 0
3 8 1 0
8 9 2 0
9 7 1 0
8 10 1 0
11 10 1 0
12 11 1 0
13 12 1 0
9 13 1 0
14 13 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 14 1 0
1 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 315.21 | Molecular Weight (Monoisotopic): 314.0419 | AlogP: 4.66 | #Rotatable Bonds: 1 |
Polar Surface Area: 20.72 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 4.78 | CX LogD: 4.78 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.67 | Np Likeness Score: -0.38 |
References
1. Baiazitov RY, Qi H, Arasu T, Lennox W, Cao L, Weetall M, Furia B, Zhuo J, Choi S, Kim MJ, Sheedy J, Davis T, Moon YC.. (2022) SAR studies toward discovery of emvododstat (PTC299), a potent dihydroorotate dehydrogenase (DHODH) inhibitor., 244 [PMID:36242990] [10.1016/j.ejmech.2022.114826] |